Skip to main content
. 2021 Jan 11;13:611179. doi: 10.3389/fnmol.2020.611179

Figure 6.

Figure 6

Bumetanide (BMT) enhanced spinal mIPSCs and visceral pain threshold in NMD rats. (A) Representative traces of mIPSCs were recorded in spinal dorsal horn neurons of NMD rats before and after incubation of BMT. (B) Bar plots and cumulative probability distributions of the amplitude of mIPSCs recorded in spinal dorsal horn neurons of NMD rats before and after incubation of BMT (**P < 0.01, n = 6 cells for each group, two-sample t-test). (C) Bar plots and cumulative probability distributions of the frequency of mIPSCs recorded in spinal dorsal horn neurons of NMD rats before and after incubation of BMT (P > 0.05, n = 6 cells for each group, two-sample t-test). (D) Behavioral changes of NMD rats after intrathecal injection of BMT at different doses (5, 50, and 500 μM, ***P < 0.001, n = 6 rats for each group, Tukey post hoc test following two-way repeated-measures ANOVA). (E) Behavioral changes of NMD rats after intrathecal injection of BMT (50 μM) for seven consecutive days (**P < 0.01, ***P < 0.001, n = 6 rats for each group, Tukey post hoc test following two-way repeated-measures ANOVA).